Respiratory Syncytial Virus: The Urgent Need for Innovative Preventive Strategies

• 2024

  Log in to bookmark this resource.

  Log in
• Fabrizio Virgili; Fabio Midulla; Fernando Maria de Benedictis
PMID: 39189291DOI: https://dx.doi.org/10.3390/pediatric16030057

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This editorial describes the challenges and urgent need for new ways to prevent respiratory syncytial virus (RSV) infections, especially in infants. RSV is a common virus that can cause serious lung problems like bronchiolitis. It highlights the importance of vaccines and monoclonal antibodies as preventive measures. While some treatments exist, they are costly and not widely available everywhere. New vaccines for adults have shown promise, and maternal immunization could protect newborns. Ongoing research aims to develop more effective solutions to reduce the global impact of RSV on health systems and vulnerable populations like young children and older adults.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Bronchiolitis; Epidemiology; Immunization, Passive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory Tract Infections; Vaccines

Institutions: Sapienza Università di Roma

---

More like this

Immunization Technologies: Time to Consider New Preventative Solutions for Respiratory Syncytial Virus Infections 2023 · Paris Cité University, Chatham House, Spanish Association of Vaccinology, Chinese Center for Disease Control and Prevention, University of Parma, Sapienza Università di Roma, Charité – Universitätsmedizin Berlin Prevention of RSV Bronchiolitis: An Ethical Issue 2024 · Bambino Gesu Children’s Hospital, University of Rome Tor Vergata, Bambino Gesù Children Hospital Knowledge, Attitudes and Behaviours of a Sample of Italian Paediatricians Towards RSV and its Preventive Strategies: A Cross-Sectional Study 2024 · Instituto Di Ricerche Farmacologiche Mario Negri (IRCCS), Università Cattolica del Sacro Cuore, Università degli Studi di Firenze, Università degli studi di Napoli Federico II

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---